Search the Site


test tubes

You are here: Home » About Us

About Us

Founders / Traders

Mark Messier is the founder of  Mark is a DOJ certified Criminal Intelligence Analyst and former IT professional, specializing in law enforcement applications.  In 2008 Mark began trading biotech stocks, using his analytical expertise to detect and capitalize on human and market patterns.  Starting with only $2200 in his trading account he has managed to bank over $400k of profit in just a few short years (Profitly).  In April 2010 Mark founded the blog to share his trading ideas with the online community.  In October 2010 BioRunUp merged with Mike Havrilla's to become the subscription website it is today. In 2012 Mark wrote a weekly biotech trading columns as a contributor to TheStreet (link).  @BioRunUp

Mike Havrilla (no longer affiliated with BioRunUp) earned Doctor of Pharmacy (PharmD) and Bachelor of Science (Biology) degrees from the University of Pittsburgh. He worked for Wyeth Labs prior to pharmacy school and was employed as a pharmacist in the retail and home infusion settings. In early 2009, Mike left his full-time retail pharmacy job to pursue an online biotech stock research and trading subscription service which he co-managed at after merging his former publishing business in October 2010; and he published over 600 articles as a contributor on Seeking Alpha since 2007. In September 2018, Mike left BioRunUp, as he was appointed Director of Investor Relations for PAVmed (NASDAQ: PAVM), which is a medical device innovator based in NY City. 


Steve Johannsen is working full time as a process chemist in the biotech industry developing synthetic routes to prepare drug candidates for clinical trials and commercial use.  He discovered the run up trading strategy after his company received a CRL and watched in horror as the share price tanked.  Steve recognized the power of the run up and immediately began applying his education and pharmaceutical background to profit from the industry he is most familiar with.  Along with traditional run-up and run-down trades Steve enjoys planning option spreads with defined risk/reward and holding these through catalyst events.  Due to his schedule he is most active during the morning hours before starting his day job.  Steve has an undergraduate degree in biochemistry and holds a master’s degree in organic chemistry.  He enjoys spending his time cooking (earned a culinary arts degree for fun), skiing, mountain biking and traveling. @SteveJo22

Chris Somers owns a large real estate office in Philadelphia, PA (CLICK HERE for link to business website). He is both an active real estate investor as well as a biotech investor / trader. To keep things focused, the majority of his trading in the market relates specifically to the biotech and pharmaceutical sector. Strategies consist of short-term trading, swing trades, option trading and/or hedging as well as longer term investing. His past career experience includes being a CPA with Deloitte & Touche as well as being a financial consultant. Chris has been invested in the market since 1998, but primary focus on biotech stocks started in 2014 and have been a member of BioRunUp since day one.


Adlai Pappy graduated this spring from Princeton University and currently works as a research assistant and in the Pediatric department at the University of Michigan hospital. He has been an investor since 2008 and on 2010, he joined BioRunUp after being introduced to the website by a college roommate, because he loved the idea of leveraging his molecular biology degree with financial investments in the life science industry. He utilizes BioRunUp’s great catalyst trading strategies with hedges through selling calls for smaller but consistent gains. He was a swimmer in college and loves to snowboard, lift, and to dance hip/hop.